Jenkem Technology Co

Jenkem Technology Co ROCE

The Return on Capital Employed (ROCE) of Jenkem Technology Co (688356.SS) as of Oct 29, 2026 is 5.38 %. In the previous year, Return on Capital Employed (ROCE) was 2.67 % — a change of 101.54% (higher).

ROCE

5.38 %

YoY

101.54%

Last updated:

In 2025, Jenkem Technology Co's return on capital employed (ROCE) was 5.38 %, a 101.54% increase from the 2.67 % ROCE in the previous year.

The Jenkem Technology Co ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
25.25 CNY
Jan 1, 2019
32.11 CNY
Jan 1, 2020
11.80 CNY
Jan 1, 2021
19.32 CNY
Jan 1, 2022
17.10 CNY
Jan 1, 2023
9.92 CNY
Jan 1, 2024
2.67 CNY
Jan 1, 2025
5.38 CNY
The Jenkem Technology Co ROCE history
YEARROCEYoY
5.38 %+101.54%
2.67 %-73.09%
9.92 %-42.00%
17.10 %-11.51%
19.32 %+63.73%
11.80 %-63.24%
32.11 %+27.16%
25.25 %+38.85%
18.18 %+144.90%
7.43 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jenkem Technology Co Stock analysis

What does Jenkem Technology Co do? Jenkem Technology Co., Ltd. generates revenue through the research, development, production, and sales of medical polyethylene glycol (PEG) and its active derivatives. The company's primary products are sold to pharmaceutical companies, research institutions, and medical device manufacturers that use these materials in drug development and production. Technical services such as patent and non-patent technology licensing, as well as R&D services, also contribute to the company's income. The firm's customer segments include entities involved in drug research, development, and production, as well as scientific research organizations. The company's business model focuses on providing specialized materials and technical support for the medical and pharmaceutical sectors. Medical polyethylene glycol and its active derivatives serve as critical components in various medical applications, driving demand from industry partners. By offering both physical products and intellectual property services, Jenkem Technology diversifies its revenue streams within the healthcare technology space. Jenkem Technology Co., Ltd. operates with a clear focus on the medical and pharmaceutical industries, targeting clients that require high-quality PEG-based materials for their research and manufacturing processes. The company's technical services, including licensing and R&D support, further strengthen its position as a supplier of essential materials and solutions in the healthcare sector. Jenkem Technology Co is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Jenkem Technology Co's Return on Capital Employed (ROCE)

Jenkem Technology Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Jenkem Technology Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Jenkem Technology Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Jenkem Technology Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Jenkem Technology Co stock

Return on Capital Employed (ROCE) of Jenkem Technology Co is 5.38 % in 2025.

Return on Capital Employed (ROCE) of Jenkem Technology Co changed from 2.67 % to 5.38 %, representing a 101.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Jenkem Technology Co since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Jenkem Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Jenkem Technology Co

All Key Metrics — Jenkem Technology Co